Method of removing antibody free light chains from blood
    5.
    发明授权
    Method of removing antibody free light chains from blood 有权
    从血液中清除抗体自由轻链的方法

    公开(公告)号:US07875183B2

    公开(公告)日:2011-01-25

    申请号:US11599849

    申请日:2006-11-15

    摘要: There is provided a method of reducing blood free light chain concentration in a subject, the method comprising the step of subjecting the subject's blood to haemodialysis, haemodiafiltration or haemofiltration. There is also provided the use of a dialysis membrane which is a membrane that allows passage of molecules having a molecular weight of up to 45 kDa in presence of whole blood, and has a molecular weight exclusion limit in water of about 200 kDa in the preparation of a haemodialysis unit for conducting haemodialysis, haemodiafiltration or haemofiltration on a subject to reduce blood free light chain concentration in the patient.

    摘要翻译: 本发明提供减少受试者血液中无血液轻链浓度的方法,该方法包括使受试者的血液进行血液透析,血液透析或血液透析的步骤。 还提供了透析膜的使用,该透析膜是允许在全血存在下具有高达45kDa分子量的分子通过的膜,并且在制剂中具有约200kDa水分子排阻极限 的血液透析单元,用于对受试者进行血液透析,血液透析过滤或血液过滤,以减少患者中的血液轻链浓度。

    Method of removing antibody free light chains from blood
    7.
    发明申请
    Method of removing antibody free light chains from blood 有权
    从血液中清除抗体自由轻链的方法

    公开(公告)号:US20070251882A1

    公开(公告)日:2007-11-01

    申请号:US11599849

    申请日:2006-11-15

    IPC分类号: B01D17/12 B01D15/08

    摘要: There is provided a method of reducing blood free light chain concentration in a subject, the method comprising the step of subjecting the subject's blood to haemodialysis, haemodiafiltration or haemofiltration. There is also provided the use of a dialysis membrane which is a membrane that allows passage of molecules having a molecular weight of up to 45 kDa in presence of whole blood, and has a molecular weight exclusion limit in water of about 200 kDa in the preparation of a haemodialysis unit for conducting haemodialysis, haemodiafiltration or haemofiltration on a subject to reduce blood free light chain concentration in the patient.

    摘要翻译: 本发明提供减少受试者血液中无血液轻链浓度的方法,该方法包括使受试者的血液进行血液透析,血液透析或血液透析的步骤。 还提供了透析膜的使用,该透析膜是允许在全血存在下具有高达45kDa分子量的分子通过的膜,并且在制剂中具有约200kDa水分子排阻极限 的血液透析单元,用于对受试者进行血液透析,血液透析过滤或血液过滤,以减少患者中的血液轻链浓度。